BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 2524251)

  • 1. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatopoietin A: partial characterization and trypsin activation of a hepatocyte growth factor.
    Thaler FJ; Michalopoulos GK
    Cancer Res; 1985 Jun; 45(6):2545-9. PubMed ID: 3157446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the effects of human placental HGF on rat hepatocytes.
    Hernandez J; Zarnegar R; Michalopoulos GK
    J Cell Physiol; 1992 Jan; 150(1):116-21. PubMed ID: 1370501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification and partial characterization of hepatocyte growth factor from plasma of patients with fulminant hepatic failure].
    Sakiyama O
    Fukuoka Igaku Zasshi; 1989 Jan; 80(1):60-70. PubMed ID: 2524438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NH2-terminal amino acid sequence of rabbit hepatopoietin A, a heparin-binding polypeptide growth factor for hepatocytes.
    Zarnegar R; Muga S; Enghild J; Michalopoulos G
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1370-6. PubMed ID: 2528955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes.
    Zarnegar R; Muga S; Rahija R; Michalopoulos G
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1252-6. PubMed ID: 2137248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.
    Gohda E; Tsubouchi H; Nakayama H; Hirono S; Sakiyama O; Takahashi K; Miyazaki H; Hashimoto S; Daikuhara Y
    J Clin Invest; 1988 Feb; 81(2):414-9. PubMed ID: 3276728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver regeneration studies with rat hepatocytes in primary culture.
    Michalopoulos G; Cianciulli HD; Novotny AR; Kligerman AD; Strom SC; Jirtle RL
    Cancer Res; 1982 Nov; 42(11):4673-82. PubMed ID: 6215120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA synthesis in rat hepatocytes: inhibition by a platelet factor and stimulation by an endogenous factor.
    Hayashi I; Carr BI
    J Cell Physiol; 1985 Oct; 125(1):82-90. PubMed ID: 3900103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution.
    Richmond A; Thomas HG
    J Cell Biochem; 1988 Feb; 36(2):185-98. PubMed ID: 3356754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells.
    Luetteke NC; Michalopoulos GK
    Cancer Res; 1985 Dec; 45(12 Pt 1):6331-7. PubMed ID: 2998598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of hepatocyte replication by two serum factors.
    Michalopoulos G; Houck KA; Dolan ML; Leutteke NC
    Cancer Res; 1984 Oct; 44(10):4414-9. PubMed ID: 6235912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and partial characterization of a preneoplastic antigen in liver carcinogenesis.
    Lin JC; Kligman L; Farber E
    Cancer Res; 1980 Oct; 40(10):3755-62. PubMed ID: 7438059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comitogenic effects of estrogens on DNA synthesis induced by various growth factors in cultured female rat hepatocytes.
    Ni N; Yager JD
    Hepatology; 1994 Jan; 19(1):183-92. PubMed ID: 7506224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification.
    Dell'Aquila ML; Pigott DA; Bonaquist DL; Gaffney EV
    J Natl Cancer Inst; 1984 Feb; 72(2):291-8. PubMed ID: 6582317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycerophosphorylethanolamine (GPEA) identified as an hepatocyte growth stimulator in liver extracts.
    Nelson C; Moffat B; Jacobsen N; Henzel WJ; Stults JT; King KL; McMurtrey A; Vandlen R; Spencer SA
    Exp Cell Res; 1996 Nov; 229(1):20-6. PubMed ID: 8940245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and partial characterization of a hepatocyte-derived factor promoting proliferation of cultured fat-storing cells (parasinusoidal lipocytes).
    Gressner AM; Lotfi S; Gressner G; Lahme B
    Hepatology; 1992 Nov; 16(5):1250-66. PubMed ID: 1427664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.